Results for Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 1
- Study Group: 100 Chinese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| 4:2 FTS | 4:2 FTS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 5:3 FTCA | 5:3 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 6:2 diPAP | 6:2 diPAP | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0500 |
| 6:2 FTCA | 6:2 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 6:2 FTS | 6:2 FTS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 6:2 FTUCA | 6:2 FTUCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 6:6 PFPiA | 6:6 PFPiA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 6:8 PFPiA | 6:8 PFPiA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 7:3 FTCA | 7:3 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 8:2 diPAP | 8:2 diPAP | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 8:2 FTCA | 8:2 FTCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| 8:2 FTS | 8:2 FTS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 8:2 FTUCA | 8:2 FTUCA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 8:2 PAP | 8:2 PAP | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0500 |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/ml | 96 | 0.0523 | 0.0421 | 0.0650 | 0.0256 | 0.0467 | 0.0959 | 0.228 | 95.8% | 0.0120 |
| PFBA | PFBA | NA | ng/ml | 96 | * | * | * | <LOD | 0.0582 | 0.0846 | 0.140 | 62.5% | 0.0500 |
| PFBS | PFBS | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0442 |
| PFDA | PFDA | NA | ng/ml | 96 | 0.477 | 0.406 | 0.559 | 0.281 | 0.453 | 0.739 | 1.49 | 80.2% | 0.250 |
| PFDoA | PFDoA | NA | ng/ml | 96 | * | * | * | <LOD | 0.0540 | 0.0788 | 0.134 | 56.3% | 0.0500 |
| PFDS | PFDS | NA | ng/ml | 96 | * | * | * | <LOD | 0.0104 | 0.0204 | 0.048 | 53.1% | 0.00965 |
| PFHpA | PFHpA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | 0.0574 | 0.0868 | 30.2% | 0.0500 |
| PFHxA | PFHxA | NA | ng/ml | 96 | 0.176 | 0.162 | 0.191 | 0.151 | 0.180 | 0.214 | 0.276 | 97.9% | 0.0556 |
| PFHxPA | PFHxPA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFHxS | PFHxS | NA | ng/ml | 96 | 0.767 | 0.66 | 0.891 | 0.432 | 0.789 | 1.41 | 1.81 | 100% | 0.00945 |
| PFNA | PFNA | NA | ng/ml | 96 | 0.987 | 0.870 | 1.12 | 0.65 | 0.948 | 1.33 | 2.24 | 99% | 0.250 |
| PFOA | PFOA | NA | ng/ml | 96 | 1.41 | 1.23 | 1.61 | 0.998 | 1.36 | 2.16 | 2.85 | 100% | 0.0500 |
| PFOPA | PFOPA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFOS | PFOS | NA | ng/ml | 96 | 6.51 | 5.49 | 7.73 | 3.32 | 6.05 | 11.7 | 19.3 | 100% | 0.0566 |
| PFOSA | PFOSA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| PFPeA | PFPeA | NA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFUnDA | PFUnDA | NA | ng/ml | 96 | 0.398 | 0.348 | 0.455 | 0.301 | 0.427 | 0.600 | 0.824 | 100% | 0.0500 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 2
- Study Group: 100 Vietnamese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
| 4:2 FTS | 4:2 FTS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 5:3 FTCA | 5:3 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.0500 |
| 6:2 diPAP | 6:2 diPAP | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.0500 |
| 6:2 FTCA | 6:2 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 6:2 FTS | 6:2 FTS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0500 |
| 6:2 FTUCA | 6:2 FTUCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 6:6 PFPiA | 6:6 PFPiA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0100 |
| 6:8 PFPiA | 6:8 PFPiA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 7:3 FTCA | 7:3 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.1% | 0.0500 |
| 8:2 diPAP | 8:2 diPAP | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
| 8:2 FTCA | 8:2 FTCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| 8:2 FTS | 8:2 FTS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| 8:2 FTUCA | 8:2 FTUCA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
| 8:2 PAP | 8:2 PAP | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0500 |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/ml | 99 | 0.0342 | 0.0291 | 0.0402 | 0.0197 | 0.0282 | 0.0538 | 0.114 | 97% | 0.0120 |
| PFBA | PFBA | NA | ng/ml | 99 | 0.0589 | 0.0531 | 0.0655 | <LOD | 0.0580 | 0.0736 | 0.0996 | 67.7% | 0.0500 |
| PFBS | PFBS | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0400 |
| PFDA | PFDA | NA | ng/ml | 99 | 0.559 | 0.490 | 0.636 | 0.393 | 0.541 | 0.823 | 1.28 | 87.9% | 0.250 |
| PFDoA | PFDoA | NA | ng/ml | 99 | * | * | * | <LOD | 0.0135 | 0.0226 | 0.0441 | 52.5% | 0.0500 |
| PFDS | PFDS | NA | ng/ml | 99 | * | * | * | <LOD | 0.0505 | 0.0773 | 0.127 | 59.6% | 0.0100 |
| PFHpA | PFHpA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | 0.0699 | 20.2% | 0.0500 |
| PFHxA | PFHxA | NA | ng/ml | 99 | 0.189 | 0.166 | 0.215 | 0.124 | 0.174 | 0.268 | 0.453 | 98% | 0.0600 |
| PFHxPA | PFHxPA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFHxS | PFHxS | NA | ng/ml | 99 | 1.29 | 1.14 | 1.45 | 0.787 | 1.21 | 1.81 | 3.05 | 100% | 0.0100 |
| PFNA | PFNA | NA | ng/ml | 99 | 1.10 | 0.988 | 1.22 | 0.84 | 1.08 | 1.49 | 2.21 | 99% | 0.250 |
| PFOA | PFOA | NA | ng/ml | 99 | 1.69 | 1.51 | 1.88 | 1.20 | 1.61 | 2.30 | 3.06 | 100% | 0.0600 |
| PFOPA | PFOPA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFOS | PFOS | NA | ng/ml | 99 | 7.47 | 6.38 | 8.75 | 4.17 | 7.00 | 11.5 | 22.9 | 100% | 0.191 |
| PFOSA | PFOSA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0100 |
| PFPeA | PFPeA | NA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
| PFUnDA | PFUnDA | NA | ng/ml | 99 | 0.453 | 0.391 | 0.525 | 0.309 | 0.443 | 0.740 | 1.12 | 98% | 0.0500 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 110 | * | * | * | <LOD | <LOD | 0.022 | 0.163 | 24.5% | 0.0313 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 110 | 0.174 | 0.142 | 0.213 | 0.0945 | 0.165 | 0.329 | 1.350 | 95.5% | 0.0277 ng/mL |
| PFBS | PFBS | NA | ng/mL | 110 | * | * | * | <LOD | <LOD | <LOD | 0.0680 | 11.8% | 0.0411 ng/mL |
| PFDA | PFDA | NA | ng/mL | 110 | 0.245 | 0.216 | 0.278 | 0.160 | 0.254 | 0.334 | 0.767 | 100% | 0.0349 ng/mL |
| PFDoA | PFDoA | NA | ng/mL | 110 | 0.0191 | 0.0166 | 0.0221 | <LOD | 0.0193 | 0.0303 | 0.0595 | 70.0% | 0.0114 ng/mL |
| PFHpA | PFHpA | NA | ng/mL | 110 | 0.0483 | 0.0395 | 0.0591 | 0.0246 | 0.0543 | 0.0901 | 0.269 | 87.3% | 0.010 ng/mL |
| PFHxS | PFHxS | NA | ng/mL | 110 | 1.43 | 1.19 | 1.73 | 0.917 | 1.52 | 2.43 | 6.87 | 99.1% | 0.0206 ng/mL |
| PFNA | PFNA | NA | ng/mL | 110 | 0.994 | 0.920 | 1.07 | 0.730 | 0.984 | 1.35 | 1.86 | 100% | 0.0154 ng/mL |
| PFOA | PFOA | NA | ng/mL | 110 | 1.97 | 1.76 | 2.19 | 1.36 | 1.99 | 2.92 | 4.70 | 100% | 0.0087 ng/mL |
| PFOS | PFOS | NA | ng/mL | 110 | 7.00 | 6.12 | 8.00 | 4.66 | 7.10 | 10.4 | 25.8 | 100% | 0.0621 ng/mL |
| PFOSA | PFOSA | NA | ng/mL | 110 | * | * | * | <LOD | 0.0254 | 0.0487 | 0.195 | 52.7% | 0.0225 ng/mL |
| PFUnDA | PFUnDA | NA | ng/mL | 110 | 0.128 | 0.111 | 0.148 | 0.0737 | 0.123 | 0.195 | 0.533 | 100% | 0.0254 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 337 | * | * | * | <LOD | 0.00732 | 0.0218 | 0.0865 | 51.7% | 0.00682 ng/mL | ○ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 337 | 0.120 | 0.106 | 0.136 | 0.0686 | 0.124 | 0.202 | 0.514 | 98.4% | 0.0114 ng/mL | ○ |
| PFDA | PFDA | NA | ng/mL | 337 | 0.162 | 0.146 | 0.180 | 0.0901 | 0.161 | 0.262 | 0.522 | 79.1% | 0.0877 ng/mL | ○ |
| PFDoA | PFDoA | NA | ng/mL | 337 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.148 ng/mL | ○ |
| PFHpA | PFHpA | NA | ng/mL | 337 | * | * | * | <LOD | 0.0189 | 0.0480 | 0.135 | 61.4% | 0.0121 ng/mL | ○ |
| PFHxS | PFHxS | NA | ng/mL | 337 | 1.09 | 0.952 | 1.26 | 0.606 | 1.13 | 1.85 | 4.59 | 99.5% | 0.0538 ng/mL | ○ |
| PFNA | PFNA | NA | ng/mL | 337 | 0.739 | 0.660 | 0.827 | 0.497 | 0.764 | 1.18 | 1.95 | 99.5% | 0.0282 ng/mL | ○ |
| PFOA | PFOA | NA | ng/mL | 337 | 1.42 | 1.26 | 1.60 | 1.04 | 1.63 | 2.34 | 4.07 | 99.5% | 0.0426 ng/mL | ○ |
| PFOS | PFOS | NA | ng/mL | 337 | 5.07 | 4.53 | 5.68 | 3.41 | 5.05 | 7.82 | 17.6 | 99.7% | 0.0943 ng/mL | ○ |
| PFOSA | PFOSA | NA | ng/mL | 337 | * | * | * | <LOD | <LOD | 0.0246 | 0.108 | 29.2% | 0.0212 ng/mL | ○ |
| PFUnDA | PFUnDA | NA | ng/mL | 337 | 0.0841 | 0.0743 | 0.0952 | 0.0447 | 0.0820 | 0.138 | 0.363 | 80.3% | 0.0371 ng/mL | ○ |
Footnotes
- ○Expanded BEST data from 337 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Project: California Regional Exposure Study, Los Angeles County (CARE-LA)
- Study Group: 430 adults (age 18 and up) living in Los Angeles County
- Sample Collection Date:
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | 0.0147 | 0.0554 | 35.7% | 0.0115 ng/mL | ▶ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 425 | 0.0678 | 0.0589 | 0.0780 | 0.0396 | 0.0558 | 0.0953 | 0.340 | 100% | 0.0114 ng/mL | ▶ |
| PFBS | PFBS | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | <LOD | 0.0357 | 5.5% | 0.0303 ng/mL | ▶ |
| PFDA | PFDA | NA | ng/mL | 425 | * | * | * | <LOD | 0.0795 | 0.164 | 0.321 | 62.3% | 0.0560 ng/mL | ▶ |
| PFDoA | PFDoA | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.110 ng/mL | ▶ |
| PFHpA | PFHpA | NA | ng/mL | 425 | * | * | * | <LOD | 0.0280 | 0.0447 | 0.0981 | 52.0% | 0.0256 ng/mL | ▶ |
| PFHxS | PFHxS | NA | ng/mL | 425 | 0.689 | 0.585 | 0.813 | 0.418 | 0.787 | 1.23 | 2.39 | 98.5% | 0.0177 ng/mL | ▶ |
| PFNA | PFNA | NA | ng/mL | 425 | 0.298 | 0.263 | 0.339 | 0.195 | 0.320 | 0.471 | 1.16 | 96.9% | 0.0424 ng/mL | ▶ |
| PFOA | PFOA | NA | ng/mL | 425 | 1.04 | 0.920 | 1.17 | 0.732 | 1.17 | 1.52 | 3.06 | 99.8% | 0.0606 ng/mL | ▶ |
| PFOS | PFOS | NA | ng/mL | 425 | 2.20 | 1.87 | 2.60 | 1.41 | 2.38 | 3.91 | 8.78 | 98.0% | 0.0615 ng/mL | ▶ |
| PFOSA | PFOSA | NA | ng/mL | 425 | * | * | * | <LOD | <LOD | 0.0152 | 0.0611 | 26.7% | 0.0144 ng/mL | ▶ |
| PFUnDA | PFUnDA | NA | ng/mL | 425 | 0.0721 | 0.0619 | 0.0840 | 0.0336 | 0.0735 | 0.136 | 0.350 | 77.6% | 0.0285 ng/mL | ▶ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ▶CARE-LA data were weighted (a statistical method to adjust over-represented and under-represented demographic characteristics in a study sample) so that the summary results adequately reflect the population of California’s Los Angeles County. Unweighted results are available to download on the California Regional Exposure Study, Los Angeles County (CARE-LA) project page.
Project: California Regional Exposure Study, Region 2 (CARE-2)
- Study Group: 359 adults (age 18 and up) living in Riverside, San Bernardino, Imperial, Mono, and Inyo counties
- Sample Collection Date:
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | 0.0312 | 16.4% | 0.0115 ng/mL | ◀ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 358 | 0.0344 | 0.0298 | 0.0397 | 0.0178 | 0.0355 | 0.0580 | 0.204 | 81.2% | 0.0114 ng/mL | ◀ |
| PFBS | PFBS | NA | ng/mL | 357 | * | * | * | <LOD | <LOD | <LOD | 0.0379 | 9.8% | 0.0303 ng/mL | ▽ |
| PFDA | PFDA | NA | ng/mL | 358 | * | * | * | <LOD | 0.0768 | 0.144 | 0.252 | 63.3% | 0.0560 ng/mL | ◀ |
| PFDoA | PFDoA | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.01% | 0.110 ng/mL | ◀ |
| PFHpA | PFHpA | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | 0.0536 | 0.101 | 43.6% | 0.0256 ng/mL | ◀ |
| PFHxS | PFHxS | NA | ng/mL | 358 | 0.798 | 0.669 | 0.953 | 0.465 | 0.837 | 1.72 | 3.20 | 99.8% | 0.0177 ng/mL | ◀ |
| PFNA | PFNA | NA | ng/mL | 358 | 0.211 | 0.181 | 0.246 | 0.132 | 0.256 | 0.374 | 0.775 | 89.5% | 0.0424 ng/mL | ◀ |
| PFOA | PFOA | NA | ng/mL | 358 | 0.987 | 0.866 | 1.12 | 0.668 | 1.13 | 1.77 | 2.53 | 98.8% | 0.0606 ng/mL | ◀ |
| PFOS | PFOS | NA | ng/mL | 357 | 2.41 | 2.05 | 2.82 | 1.48 | 2.88 | 4.89 | 7.14 | 98.5% | 0.0615 ng/mL | ▽ |
| PFOSA | PFOSA | NA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | 0.0329 | 14.9% | 0.0144 ng/mL | ◀ |
| PFUnDA | PFUnDA | NA | ng/mL | 358 | * | * | * | <LOD | 0.0416 | 0.0929 | 0.258 | 61.3% | 0.0285 ng/mL | ◀ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ◀CARE-2 data from 358 participants were weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Riverside, San Bernardino, Imperial, Mono, and Inyo counties. Unweighted results are available to download on the California Regional Exposure Study, Region 2 (CARE-2) project page.
- ▽CARE-2 data from 357 participants were weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Riverside, San Bernardino, Imperial, Mono, and Inyo counties. Unweighted results are available to download on the California Regional Exposure Study, Region 2 (CARE-2) project page.
Project: California Regional Exposure Study, Region 3 (CARE-3)
- Study Group: 90 adults (age 18 and up) living in San Diego and Orange counties
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 89 | * | * | * | <LOD | <LOD | <LOD | 0.0250 | 16.9% | 0.0115 ng/mL | ⌂ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 88 | 0.0363 | 0.0266 | 0.0494 | <LOD | 0.0332 | 0.082 | 0.238 | 65.9% | 0.0114 ng/mL | ⌂ |
| PFBS | PFBS | NA | ng/mL | 79 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.0303 ng/mL | ⌂ |
| PFDA | PFDA | NA | ng/mL | 89 | 0.0942 | 0.0802 | 0.111 | <LOD | 0.0926 | 0.174 | 0.234 | 67.4% | 0.0560 ng/mL | ⌂ |
| PFDoA | PFDoA | NA | ng/mL | 80 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.110 ng/mL | ⌂ |
| PFHpA | PFHpA | NA | ng/mL | 82 | * | * | * | <LOD | <LOD | 0.0377 | 0.0690 | 39.0% | 0.0256 ng/mL | ⌂ |
| PFHxS | PFHxS | NA | ng/mL | 89 | 0.670 | 0.517 | 0.868 | 0.393 | 0.796 | 1.33 | 2.69 | 97.8% | 0.0177 ng/mL | ⌂ |
| PFNA | PFNA | NA | ng/mL | 89 | 0.295 | 0.245 | 0.356 | 0.216 | 0.335 | 0.524 | 0.762 | 92.1% | 0.0424 ng/mL | ⌂ |
| PFOA | PFOA | NA | ng/mL | 89 | 0.901 | 0.733 | 1.11 | 0.702 | 1.03 | 1.48 | 2.21 | 95.5% | 0.0606 ng/mL | ⌂ |
| PFOS | PFOS | NA | ng/mL | 89 | 1.75 | 1.34 | 2.28 | 1.01 | 2.30 | 3.92 | 5.22 | 95.5% | 0.0615 ng/mL | ⌂ |
| PFOSA | PFOSA | NA | ng/mL | 89 | * | * | * | <LOD | <LOD | <LOD | 0.0328 | 20.2% | 0.0144 ng/mL | ⌂ |
| PFUnDA | PFUnDA | NA | ng/mL | 89 | 0.0804 | 0.066 | 0.098 | 0.0372 | 0.0839 | 0.161 | 0.286 | 80.9% | 0.0285 ng/mL | ⌂ |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- ⌂Due to the COVID-19 emergency, CARE-3 was stopped early and only 90 people completed all study steps. The results from this small non-representative sample cannot be generalized to the population of San Diego and Orange counties.
Project: California Teachers Study (CTS)
- Study Group: 2,869 female professional school employees
- Sample Collection Date:
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | EtPFOSAAcOH | NA | ng/mL | 1759 | 0.031 | 0.029 | 0.032 | 0.015 | 0.03 | 0.06 | 0.2 | 84.5% | 0.011 |
| Me-PFOSA-AcOH | MePFOSAAcOH | NA | ng/mL | 1759 | 0.2 | 0.19 | 0.21 | 0.1 | 0.2 | 0.41 | 1.3 | 98.4% | 0.013 |
| PFBS | PFBS | NA | ng/mL | 614 | *,# | * | * | <LOD | <LOD | <LOD | 0.067 | 18.4% | 0.022 |
| PFDA | PFDA | NA | ng/mL | 1759 | 0.22 | 0.21 | 0.23 | 0.15 | 0.23 | 0.35 | 0.67 | 94.7% | 0.032 |
| PFDoA | PFDoA | NA | ng/mL | 1737 | * | * | * | <LOD | <LOD | <LOD | 0.093 | 10.8% | 0.036 |
| PFHpA | PFHpA | NA | ng/mL | 1759 | 0.054 | 0.052 | 0.057 | <LOD | 0.054 | 0.11 | 0.28 | 74% | 0.015 |
| PFHxS | PFHxS | NA | ng/mL | 1759 | 1.62 | 1.56 | 1.68 | 1.04 | 1.58 | 2.50 | 6.24 | 99.9% | 0.012 |
| PFNA | PFNA | NA | ng/mL | 1719 | 0.92 | 0.89 | 0.95 | 0.67 | 0.95 | 1.3 | 2.3 | 99.7% | 0.014 |
| PFOA | PFOA | NA | ng/mL | 1759 | 2.46 | 2.39 | 2.53 | 1.69 | 2.5 | 3.63 | 6.22 | 99.9% | 0.029 |
| PFOS | PFOS | NA | ng/mL | 1759 | 6.8 | 6.56 | 7.04 | 4.57 | 7.14 | 10.9 | 19.5 | 99.8% | 0.083 |
| PFOSA | PFOSA | NA | ng/mL | 1597 | 0.036 | 0.034 | 0.039 | <LOD | 0.036 | 0.075 | 0.25 | 74.1% | 0.01 |
| PFUnDA | PFUnDA | NA | ng/mL | 1759 | 0.13 | 0.12 | 0.13 | 0.081 | 0.14 | 0.23 | 0.42 | 96.8% | 0.01 |
Footnotes
- # As of March 2013, PFBuS is no longer measured due to instrumental background interference.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of detection (LOD) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | EtPFOSAAcOH | NA | ng/mL | 101 | 0.016 | 0.014 | 0.018 | <LOD | 0.016 | 0.023 | 0.060 | 65.3% | 0.011 |
| Me-PFOSA-AcOH | MePFOSAAcOH | NA | ng/mL | 101 | 0.16 | 0.13 | 0.18 | 0.086 | 0.14 | 0.24 | 0.61 | 100% | 0.013 |
| PFBS | PFBS | NA | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | 0.020 | 6.9% | 0.02 |
| PFDA | PFDA | NA | ng/mL | 101 | 0.899 | 0.783 | 1.03 | 0.512 | 0.721 | 1.72 | 2.63 | 100% | 0.032 |
| PFDoA | PFDoA | NA | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.040 |
| PFHpA | PFHpA | NA | ng/mL | 101 | 0.13 | 0.11 | 0.15 | 0.06 | 0.12 | 0.22 | 0.63 | 75.2% | 0.059 |
| PFHxS | PFHxS | NA | ng/mL | 101 | 2.26 | 2 | 2.54 | 1.61 | 2.27 | 3.13 | 4.64 | 100% | 0.012 |
| PFNA | PFNA | NA | ng/mL | 101 | 1.15 | 1.06 | 1.25 | 0.888 | 1.13 | 1.49 | 2.21 | 100% | 0.075 |
| PFOA | PFOA | NA | ng/mL | 101 | 3.75 | 3.37 | 4.17 | 2.96 | 3.86 | 4.89 | 9.54 | 100% | 0.301 |
| PFOS | PFOS | NA | ng/mL | 101 | 12.5 | 11.3 | 13.8 | 10.1 | 12.7 | 16.8 | 24.7 | 100% | 0.083 |
| PFOSA | PFOSA | NA | ng/mL | 101 | 0.032 | 0.027 | 0.037 | 0.019 | 0.029 | 0.050 | 0.151 | 95.0% | 0.009 |
| PFUnDA | PFUnDA | NA | ng/mL | 101 | 0.24 | 0.21 | 0.27 | 0.17 | 0.26 | 0.37 | 0.53 | 100% | 0.010 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 77 | * | * | * | <LOD | 0.012 | 0.021 | 0.026 | 0.011 |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 77 | 0.067 | 0.055 | 0.082 | 0.037 | 0.064 | 0.10 | 0.20 | 0.013 |
| PFBS | PFBS | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.022 |
| PFDA | PFDA | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | 0.035 | 0.64 | 0.032 |
| PFDoA | PFDoA | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.036 |
| PFHpA | PFHpA | NA | ng/mL | 77 | * | * | * | <LOD | <LOD | 0.071 | 0.14 | 0.059 |
| PFNA | PFNA | NA | ng/mL | 77 | 0.733 | 0.621 | 0.865 | 0.504 | 0.791 | 1.11 | 1.74 | 0.075 |
| PFOA | PFOA | NA | ng/mL | 77 | * | * | * | <LOD | 0.474 | 0.811 | 1.25 | 0.30 |
| PFOS | PFOS | NA | ng/mL | 77 | 2.55 | 2.20 | 2.95 | 1.78 | 2.43 | 4.11 | 4.90 | 0.083 |
| PFOSA | PFOSA | NA | ng/mL | 77 | 0.019 | 0.016 | 0.022 | 0.012 | 0.017 | 0.026 | 0.049 | 0.01 |
| PFUnDA | PFUnDA | NA | ng/mL | 77 | 0.131 | 0.101 | 0.170 | 0.0730 | 0.165 | 0.261 | 0.474 | 0.01 |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 1
- Study Group: 460 pregnant individuals
- Sample Collection Date:
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 200 | * | * | * | <LOD | <LOD | 0.0185 | 0.0288 | 29.0% | 0.0164 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 200 | 0.0446 | 0.0379 | 0.0526 | 0.0177 | 0.0373 | 0.091 | 0.361 | 79.5% | 0.0147 ng/mL |
| PFDA | PFDA | NA | ng/mL | 200 | 0.198 | 0.174 | 0.226 | 0.0950 | 0.212 | 0.373 | 0.908 | 83.0% | 0.0652 ng/mL |
| PFDoA | PFDoA | NA | ng/mL | 200 | * | * | * | <LOD | <LOD | <LOD | 0.317 | 8.0% | 0.174 ng/mL |
| PFHpA | PFHpA | NA | ng/mL | 200 | 0.0453 | 0.0397 | 0.0515 | 0.0220 | 0.0484 | 0.0954 | 0.198 | 83.5% | 0.0149 ng/mL |
| PFHxS | PFHxS | NA | ng/mL | 200 | 0.904 | 0.818 | 0.998 | 0.558 | 0.861 | 1.43 | 2.83 | 100% | 0.0250 ng/mL |
| PFNA | PFNA | NA | ng/mL | 200 | 0.647 | 0.596 | 0.703 | 0.442 | 0.644 | 0.952 | 1.74 | 100% | 0.0302 ng/mL |
| PFOA | PFOA | NA | ng/mL | 200 | 1.243 | 1.154 | 1.339 | 0.898 | 1.29 | 1.77 | 2.81 | 100% | 0.0391 ng/mL |
| PFOS | PFOS | NA | ng/mL | 200 | 4.20 | 3.82 | 4.62 | 2.62 | 4.47 | 6.75 | 12.3 | 100% | 0.0565 ng/mL |
| PFOSA | PFOSA | NA | ng/mL | 200 | * | * | * | <LOD | <LOD | 0.00661 | 0.0266 | 33.5% | 0.00460 ng/mL |
| PFUnDA | PFUnDA | NA | ng/mL | 200 | 0.124 | 0.107 | 0.144 | 0.0483 | 0.118 | 0.275 | 0.717 | 78.0% | 0.0430 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
- Study Group: 540 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| 4:2 FTS | 4:2 FTS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0463 | 6.2% | 0.0372 ng/mL |
| 5:3 FTCA | 5:3 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0500 ng/mL |
| 6:2 diPAP | 6:2 diPAP | ng/mL | 277 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.0645 ng/mL |
| 6:2 FTCA | 6:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 6:2 FTS | 6:2 FTS | ng/mL | 240 | * | * | * | <LOD | <LOD | <LOD | 0.781 | 20.8% | 0.188 ng/mL |
| 6:2 FTUCA | 6:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
| 6:6 PFPiA | 6:6 PFPiA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
| 7:3 FTCA | 7:3 FTCA | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.8% | 0.0622 ng/mL |
| 8:2 diPAP | 8:2 diPAP | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/ml |
| 8:2 FTCA | 8:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTS | 8:2 FTS | ng/mL | 290 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.0500 ng/mL |
| 8:2 FTUCA | 8:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0280 ng/mL |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0179 | 0.0398 | 35.6% | 0.0131 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.107 | 0.287 | 45.5% | 0.0638 ng/mL |
| PFBA | PFBA | ng/mL | 292 | 0.0577 | 0.0550 | 0.0606 | <LOD | 0.0594 | 0.0770 | 0.121 | 65.8% | 0.0500 ng/mL |
| PFBS | PFBS | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0119 | 0.0283 | 25.0% | 0.0140 ng/mL |
| PFDA | PFDA | ng/mL | 292 | 0.213 | 0.196 | 0.231 | 0.135 | 0.189 | 0.320 | 0.752 | 99.0% | 0.0542 ng/mL |
| PFDoA | PFDoA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0854 | 16.4% | 0.0500 ng/mL |
| PFDS | PFDS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0308 | 5.8% | 0.0274 ng/mL |
| PFHpA | PFHpA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.103 | 24.0% | 0.0500 ng/ml |
| PFHxA | PFHxA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0925 | 5.5% | 0.0818 ng/mL |
| PFHxPA | PFHxPA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFHxS | PFHxS | ng/mL | 292 | 0.743 | 0.690 | 0.800 | 0.496 | 0.720 | 1.00 | 2.66 | 100% | 0.0195 ng/ml |
| PFNA | PFNA | ng/mL | 292 | 0.542 | 0.509 | 0.578 | 0.372 | 0.527 | 0.774 | 1.39 | 100% | 0.0487 ng/mL |
| PFOA | PFOA | ng/mL | 292 | 1.01 | 0.942 | 1.09 | 0.631 | 1.02 | 1.55 | 2.88 | 100% | 0.0539 ng/mL |
| PFOS | PFOS | ng/mL | 292 | 3.10 | 2.88 | 3.33 | 2.05 | 3.09 | 4.41 | 9.07 | 100% | 0.316 ng/mL |
| PFOSA | PFOSA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.4% | 0.0173 ng/mL |
| PFPeA | PFPeA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0255 | 6.5% | 0.0235 ng/mL |
| PFUnDA | PFUnDA | ng/mL | 292 | 0.129 | 0.115 | 0.145 | 0.0646 | 0.118 | 0.275 | 0.726 | 81.2% | 0.0481 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
- Study Group: 300 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| 4:2 FTS | 4:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0372 ng/mL |
| 5:3 FTCA | 5:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0500 ng/mL |
| 6:2 diPAP | 6:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0645 ng/mL |
| 6:2 FTCA | 6:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.2% | 0.250 ng/mL |
| 6:2 FTS | 6:2 FTS | ng/mL | 87 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.188 ng/mL |
| 6:2 FTUCA | 6:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
| 6:6 PFPiA | 6:6 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
| 6:8 PFPiA | 6:8 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.198 ng/mL |
| 7:3 FTCA | 7:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0622 ng/mL |
| 8:2 diPAP | 8:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTCA | 8:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTS | 8:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0500 ng/mL |
| 8:2 FTUCA | 8:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0280 ng/mL |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0136 | 11.5% | 0.0131 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 22.9% | 0.0638 ng/mL |
| PFBA | PFBA | ng/mL | 96 | 0.0760 | 0.0697 | 0.0828 | 0.0645 | 0.0845 | 0.0990 | 0.117 | 82.3% | 0.0500 ng/mL |
| PFBS | PFBS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0140 ng/mL |
| PFDA | PFDA | ng/mL | 96 | 0.187 | 0.160 | 0.220 | 0.109 | 0.169 | 0.285 | 0.613 | 99.0% | 0.0542 ng/mL |
| PFDoA | PFDoA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0741 | 17.7% | 0.0500 ng/mL |
| PFDS | PFDS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 6.3% | 0.0274 ng/mL |
| PFHpA | PFHpA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0107 ng/mL |
| PFHxA | PFHxA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.108 ng/mL |
| PFHxPA | PFHxPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFHxS | PFHxS | ng/mL | 96 | 0.416 | 0.366 | 0.473 | 0.272 | 0.386 | 0.606 | 0.951 | 100% | 0.0472 ng/mL |
| PFNA | PFNA | ng/mL | 96 | 0.406 | 0.360 | 0.457 | 0.263 | 0.426 | 0.564 | 0.830 | 100% | 0.0767 ng/mL |
| PFOA | PFOA | ng/mL | 96 | 0.892 | 0.783 | 1.02 | 0.604 | 0.895 | 1.29 | 2.00 | 100% | 0.0539 ng/mL |
| PFOPA | PFOPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFOS | PFOS | ng/mL | 96 | 2.39 | 2.08 | 2.75 | 1.47 | 2.47 | 3.56 | 5.42 | 100% | 0.316 ng/mL |
| PFOSA | PFOSA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0173 ng/mL |
| PFPeA | PFPeA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0235 ng/mL |
| PFUnDA | PFUnDA | ng/mL | 96 | 0.121 | 0.0990 | 0.147 | 0.0584 | 0.108 | 0.215 | 0.532 | 79.2% | 0.0481 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.